Table 2.2.
Gene | Protein | PEO Phenotype | Inheritance | Reference |
---|---|---|---|---|
TYMP | Thymidine phosphorylase | MNGIE | AR | Nishino et al. (2000) |
SLC25A4 | Adenine nucleotide translocator 1 | PEO | AD/AR | Kaukonen et al. (2000) |
TK2 | Thymidine kinase 2 | PEO/PEO-plus | AR | Saada et al. (2001) and Garone et al. (2018) |
DGUOK | Deoxyguanosine kinase | PEO | AR | Mandel et al. (2001) and Ronchi et al. (2012) |
POLG | Polymerase gamma catalytic subunit | PEO/PEO-plus/SANDO/MNGIE-like | AD/AR | Van Goethem et al. (2001) and Van Goethem et al. (2003a) |
TWNK | Twinkle | PEO | AD/AR | Spelbrink et al. (2001) |
POLG2 | Polymerase gamma subunit 2 | PEO | AD/AR | Longley et al. (2006) |
RRM2B | P53-subunit of ribonucleotide reductase | PEO/KSS/MNGIE-like | AD/AR | Bourdon et al. (2007) and Pitceathly et al. (2012) |
OPA1 | GTPase mitochondrial fusion | PEO-plus | AD | Hudson et al. (2008) |
MGME1 | Mitochondrial genome maintenance exonuclease 1 | PEO/KSS | AR | Kornblum et al. (2013) |
DNA2 | DNA replication ATP-dependent | PEO | AD | Ronchi et al. (2013) |
SPG7 | Paraplegin | PEO-plus | AR | Wedding et al. (2014) |
AFGL2 | AFG3-like protein 2 | PEO-plus | AD | Gorman et al. (2015) |
RNASEH1 | Ribonuclease H1 | PEO/PEO-plus | AR | Reyes et al. (2015) and Bugiardini et al. (2017) |
C1QBP | Complement component C1q binding protein | PEO | AR | Feichtinger et al. (2017) |
TOP3A | DNA topoisomerase 3 alpha | PEO-plus | AR | Nicholls et al. (2018) |
GMPR | GMP reductase 1 | PEO | AD | Sommerville et al. (2020) |
LIG3 | Ligase III | MNGIE-like | AR | Bonora et al. (2021) |
RRM1 | Ribonucleotide reductase catalytic subunit | PEO/MNGIE-like | AD/AR | Shintaku et al. (2022) |
Abbreviations: AD, autosomal dominant; AR, autosomal recessive; KSS, Kearns–Sayre syndrome; MNGIE, mitochondrial neurogastrointestinal encephalomyopathy; PEO, progressive external ophthalmoplegia; SANDO, sensory ataxic neuropathy dysarthria ophthalmoplegia.